Crossmark

Montelukast, Leukotriene Inhibitor, Reduces LPS-Induced Acute Lung Inflammation and Human Neutrophil Activation

Crossref DOI link: https://doi.org/10.1016/j.arbr.2019.10.002

Published Print: 2019-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Davino-Chiovatto, Jaime Eduardo

Oliveira-Junior, Manoel Carneiro

MacKenzie, BreAnne

Santos-Dias, Alana

Almeida-Oliveira, Ana Roberta

Aquino-Junior, Jefferson Comin Jonco

Brito, Auriléia Aparecida

Rigonato-Oliveira, Nicole Cristine

Damaceno-Rodrigues, Nilsa Regina

Oliveira, Ana Paula Ligeiro

Silva, Alessandro Pereira

Consolim-Colombo, Fernanda Marciano

Aimbire, Flavio

Castro-Faria-Neto, Hugo Caire

Vieira, Rodolfo Paula
Funding

Funding for this research was provided by:

Sao Paulo Research Foundation (2012/15165-2)

FAPESP (2014/14604-8)

FAPESP (2014/23196-0)

FAPESP (2014/07500-1)

FAPESP (2014/12755-9)

CAPES
License Information

Text and Data Mining valid from 2019-11-01
More Information

This article is maintained by: Elsevier

Article Title: Montelukast, Leukotriene Inhibitor, Reduces LPS-Induced Acute Lung Inflammation and Human Neutrophil Activation

Journal Title: Archivos de Bronconeumología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.arbr.2019.10.002

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.arbres.2019.05.003

Content Type: article

Copyright: © 2019 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.